Key facts
- Farmako’s last known valuation is $2.1M (Aug 2020).
- It has raised $3.1M; the latest was Later Stage VC in Jan 2026.
- Notable investors include Y Combinator, Soma Capital, Goodwater Capital, Unpopular Ventures, HOF Capital — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Farmako
- ·The full record, as it builds
Funding rounds
No funding rounds for Farmako are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Farmako
Developer of a centralized digital medical record system designed to offer structured health records. The company's system facilitates the delivery of medicines and helps users save their medical reports and prescriptions digitally in one place, it also provides hospitals and pathology labs a management system to manage all their internal workings, enabling patients to receive medication and digitally keep their lab reports and prescriptions from different doctors.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Moradabad, India
- Founded
- 2019
- Employees
- 52
- Website
- farmako.ai/
- Ownership
- Privately Held (backing)
Farmako doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Farmako shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Farmako in its N-PORT filings yet. We sweep new filings monthly.